Sabrina Daniela da Silva

Jewish General Hospital

Papers

1

Total Citations

5

H-Index

1

About

Dr. Sabrina Daniela da Silva is a leading oncologist and researcher whose work is reshaping the landscape of head and neck cancer treatment, with a particular focus on HPV-positive disease. Her major contributions center on rethinking traditional therapeutic paradigms, championing the use of neoadjuvant therapy and exploring de-escalation strategies to reduce treatment toxicity without compromising survival. Her most-cited paper, "Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer" (2024), has already garnered 5 citations, signaling its growing influence in the field. Dr. da Silva’s research is notable for its patient-centered approach, aiming to improve quality of life for survivors while maintaining oncologic outcomes. Her work is highly relevant for clinicians and researchers seeking to personalize therapy, minimize long-term side effects, and optimize cure rates. Through her innovative studies, Dr. da Silva is helping to define a new standard of care for a growing population of younger, healthier patients with HPV-positive head and neck cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Jewish General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago